← Leaderboards
James Michael Wells
University Of Alabama At Birmingham
$3,103,783
Attributed
$3,103,783
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $472.2K · FY2014–23$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,103,783 · 2
By mechanism
R01$2,359,720 · 1
K08$744,063 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- J. Edwin Blalock$21,586,966
- Yiu-Fai Chen$5,928,369
- Amit Gaggar$7,818,359
- George Martin Solomon$1,723,350
- Sadis Matalon$21,362,558
Others in their field
Top investigators on “Molecular Target”
- David Heimbrook · Leidos Biomedical Research, Inc.$313,162,515
- Peter C Adamson · National Childhood Cancer Foundation$268,343,924
- Ralph Parchment · Leidos Biomedical Research, Inc.$190,649,509
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Mark S Klempner · Tufts Medical Center$128,021,180
- Larry Arthur$115,838,400
Research focus
Molecular TargetLungMediatingInflammationInterleukin-8b ReceptorLeadInflammatoryGlycineHypoxiaIl8rb GeneInflammatory MarkerBmpr2 GeneKnockout MiceLaboratoriesAffectGenerationsCohortComplexHuman DiseaseCellsEndothelial CellsIl8ra GeneBlood VesselsMorbidity - Disease Rate
Grant awards (10)
Matrikines and COPD-PH$472,241
R01 · FY2023 · HL · contact PI
Matrikines and COPD-PH$472,241
R01 · FY2022 · HL · contact PI
Matrikines and COPD-PH$472,241
R01 · FY2021 · HL · contact PI
Matrikines and COPD-PH$472,241
R01 · FY2020 · HL · contact PI
Matrikines and COPD-PH$470,756
R01 · FY2019 · HL · contact PI
The Role of PGP in COPD-associated Pulmonary Hypertension$161,801
K08 · FY2018 · HL · contact PI
The Role of PGP in COPD-associated Pulmonary Hypertension$161,801
K08 · FY2017 · HL · contact PI
The Role of PGP in COPD-associated Pulmonary Hypertension$161,801
K08 · FY2016 · HL · contact PI
The Role of PGP in COPD-associated Pulmonary Hypertension$129,330
K08 · FY2015 · HL · contact PI
The Role of PGP in COPD-associated Pulmonary Hypertension$129,330
K08 · FY2014 · HL · contact PI